H1-ANTIHISTAMINES FOR THE TREATMENT OF CHILDREN WITH ALLERGIC DISEASE
- Authors: Pampura AN1, Pampura АN2
-
Affiliations:
- ФГУ «Московский НИИ педиатрии и детской хирургии» М инзравсоцразвития России
- Federal state organization «Moscow Research Institute of Pediatrics and Child Surgery»
- Issue: Vol 8, No 5 (2011)
- Pages: 54-58
- Section: Articles
- URL: https://journals.rcsi.science/raj/article/view/121231
- DOI: https://doi.org/10.36691/RJA814
- ID: 121231
Cite item
Open Access
Access granted
Subscription Access
Abstract
The article is devoted to modern approaches of H1-antihistamines for the treatment of children with allergic
disease.
disease.
Keywords
About the authors
A N Pampura
ФГУ «Московский НИИ педиатрии и детской хирургии» М инзравсоцразвития РоссииФГУ «Московский НИИ педиатрии и детской хирургии» М инзравсоцразвития России
А N Pampura
Federal state organization «Moscow Research Institute of Pediatrics and Child Surgery»Federal state organization «Moscow Research Institute of Pediatrics and Child Surgery»
References
- Nagai H., Teramachi H., Tuchiya Т. Recent Advances in the Development of Anti-allergic Drugs. Allergology International. 2006, v. 55, p. 35-42.
- Benedetti M.S., Plisnier M., Kaise J. et al. Absorption, distribution, metabolism and excretion of levocetirizine, the R-enantiomer of cetirizine, in healthy volunteers. Eur. J. Clin. Pharmacol. 2001, v. 57, p. 571-582.
- Cranswick N., Turzikova J., Hulhoven R. Levocetirizine in one-to two-year-old children: pharmacokinetic and pharmacokinetic profile. Int. J. Clin. Pharmacol. Therap. 2005, v. 43, p. 172-177.
- Adam K., Oswald I. The hypnotic effects of an antihistamine: promethazine. Br. J. Clin. Pharmacol. 1986, v. 22, p. 715-717.
- Druce H.M., Thoden W.R., Mure P. et al. Brompheniramine, loratadine, and placebo in allergic rhinitis: a placebocontrolled comparative clinical trial. J. Clin. Pharmacol. 1998, v. 38, p. 382-389.
- Scadding G. Optimal management of nasal congestion caused by allergic rhinitis in children: safety and efficacy of medical treatments. Paediatr. Drugs. 2008, v. 10, p. 151-162.
- Walker S., Khan-Wasti S., Fletcher M. et al. Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study. J. Allergy. Clin. Immunol. 2007, v. 120, p. 381-387.
- Walsh G.M. The anti-inflammatory effects of levocetirizine are they clinically relevant or just an interesting additional effect? Allergy Asthma Clin. Immunol. 2009, v. 17, p. 14.
- Ciprandi G., Cirillo I., Vizzaccaro A., Tosca M.A. Levocetirizine improves nasal obstruction and modulates cytokine pattern in patients with seasonal allergic rhinitis: a pilot study. Clin. Exp. Allergy. 2004, v. 34, p. 958-964.
- Simons F.E.R. Prospective, long-term safety evaluation of the HI-receptor antagonist cetirizine in very young children with atopic dermatitis. ETAC Study Group. Early Treatment of the Atopic Child. J. Allergy Clin. Immunol. 1999, v. 104, p. 433-440.
- Simons F.E.R. Early Prevention of Asthma in Atopic Children (EPAAC) Study Group. Safety of levocetirizine treatment in young atopic children: an 18-month study. Pediatr. Allergy Immunol. 2007, v. 18, p. 535-542.
- Grimfeld A., Holgate S.T., Canonica G.W. et al. Prophylactic management of children at risk for recurrent upper respiratory infections: the Preventia I Study. Clin. Exp. Allergy. 2004, v. 34, p. 1665-1672.
- Church K., Maurer M., Simons F. E. R. First-generation H1-antihistamines-more risk than expected . Allergy. 2010, p. 459-466.
- Ружицкая E.A, Потапова О.Н., Виноградова Т.В. и соавт. Клиническая эффективность левоцетиризина у детей с сезонным аллергическим ринитом и его влияние на количественный состав и морфологические показатели эозинофилов периферической крови. Педиатр. фармакол. 2009, № 3, с. 53-59.
- Hampel F., Ratner P., Haeusler J.M.C. Safety and tolerability of levocetirizine dihydrochloride in infants and children with allergic rhinitis or chronic urticaria. Allergy Asthma Proc. 2010, v. 31, p. 290-295.
- Sheikh A., ten Broek V.M., Brown S.G.A., Simons F.E.R. H1-antihistamines for the treatment of anaphylaxis with and without shock. Cochrane Database Syst. Rev. 2007, v. 1, CD006160.
- Starke P.R., Weaver J., Chowdhury B.A. Boxed warning added to promethazine labeling for pediatric use [letter]. N. Engl. J. Med. 2005, v. 352, p. 2653.
- Феденко Е.С. Основы рациональной терапии атопического дерматита. Рос. Аллергол. Журн. 2005, № 6, с. 32-41.
- Wahlgren C.F., Hagermark O., Bergstrom R. The antipruritic effect of a sedative and non-sedative antihistamine in atopic dermatitis. Br. J. Dermatol. 1990, v. 122, p. 545-551.
- Heyer G.R., Hornstein O.P. Recent studies of cutaneous nociception in atopic and non-atopic subjects. J. Dermatol. 1999, v. 26 (2), p. 77-86.
- Гребенченко Е.И., Гущин И.С., Феденко Е.С. Фармакологический контроль холинергической составляющей кожного зуда у больных атопическим дерматитом. Рос. Аллергол. Журн. 2009, № 5, с. 3-10.
